Skip to main content
Top
Published in: BMC Neurology 1/2021

Open Access 01-12-2021 | Neuromyelitis Optica Spectrum Disease | Research

Association of neutrophil-to-lymphocyte ratio (NLR) with the prognosis of first attack neuromyelitis optica spectrum disorder (NMOSD): a retrospective cohort study

Authors: Haojie Xie, Yi Zhao, Chunyang Pan, Jinwei Zhang, Yongyan Zhou, Yanfei Li, Ranran Duan, Yaobing Yao, Zhe Gong, Junfang Teng, Yanjie Jia

Published in: BMC Neurology | Issue 1/2021

Login to get access

Abstract

Background

To investigate the relationship between the neutrophil-to-lymphocyte ratio (NLR) and prognosis after the first attack of optic neuromyelitis optica spectrum disorder (NMOSD).

Methods

In this retrospective study, we included the medical records of 324 patients with first episode NMOSD and collected data on clinical parameters. Follow-up extended disability status scale (EDSS) score and relapse rate were analyzed using logistic regression models to determine the independent effect of NLR on outcomes; receiver operating characteristic (ROC) curves were applied to analyze the predictive value of NLR for the prognosis of NMOSD. Interaction and stratification analyses were used to explore the association between NLR and prognosis of patients with NMOSD, and Kaplan-Meier analysis was used to investigate the relationship between NLR and outcome. The association between NLR level with relapse rate and poor recovery was assessed by a Cox regression analysis.

Results

Patients in the high-NLR group had significantly higher EDSS scores and relapse rates at follow-up (both, P < 0.001) than did those in the low-NLR group. Univariate analysis showed revealed that NLR was significantly associated with relapse (odds ratio [OR] = 1.28, 95% confidence interval [CI]: 1.16–1.41, P < 0.001) and poor recovery (OR = 1.32, 95% CI: 1.20–1.46, P < 0.001), and these associations remained significant, even after multifactorial analysis (OR = 1.33, 95% CI: 1.11–1.59, P = 0.002; OR = 1.23, 95% CI: 1.06–1.43, P = 0.007, respectively). Stratified analysis showed that sex, platelet-to-lymphocyte ratio (PLR) level, and lymphocyte-to-monocyte technical ratio (LMR) level were strongly associated with relapse owing to elevated NLR; Kaplan-Meier survival curve analysis showed that the median time to relapse was significantly lower in the high-NLR group than in the low-NLR group (P < 0.001). A multivariate analysis showed a significant relationship between NLR level with relapse (HR = 1.07, 95%CI: 1.03–1.10, P = 0.001) and poor recovery (HR = 1.08, 95%CI: 1.04–1.11, P = 0.001).

Conclusions

NLR may be used as a prognostic indicator for first onset NMOSD, and a high NLR may be significantly associated with high relapse rates and poor recovery.
Literature
1.
go back to reference Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–89.CrossRef Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–89.CrossRef
2.
go back to reference Yao X, Adams MS, Jones PD, Diederich CJ, Verkman AS. Noninvasive, targeted creation of neuromyelitis optica pathology in AQP4-IgG seropositive rats by pulsed focused ultrasound. J Neuropathol Exp Neurol. 2019;78(1):47–56.CrossRef Yao X, Adams MS, Jones PD, Diederich CJ, Verkman AS. Noninvasive, targeted creation of neuromyelitis optica pathology in AQP4-IgG seropositive rats by pulsed focused ultrasound. J Neuropathol Exp Neurol. 2019;78(1):47–56.CrossRef
3.
go back to reference Yandamuri SS, Jiang R, Sharma A, Cotzomi E, Zografou C, Ma AK, et al. High-throughput investigation of molecular and cellular biomarkers in NMOSD. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e852.CrossRef Yandamuri SS, Jiang R, Sharma A, Cotzomi E, Zografou C, Ma AK, et al. High-throughput investigation of molecular and cellular biomarkers in NMOSD. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e852.CrossRef
4.
go back to reference Tortorella C, Ruggieri M, Di Monte E, Ceci E, Iaffaldano P, Direnzo V, et al. Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica. J Neurol Neurosurg Psychiatry. 2011;82(12):1355–9.CrossRef Tortorella C, Ruggieri M, Di Monte E, Ceci E, Iaffaldano P, Direnzo V, et al. Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica. J Neurol Neurosurg Psychiatry. 2011;82(12):1355–9.CrossRef
5.
go back to reference Hajibandeh S, Hajibandeh S, Hobbs N, Mansour M. Neutrophil-to-lymphocyte ratio predicts acute appendicitis and distinguishes between complicated and uncomplicated appendicitis: a systematic review and meta-analysis. Am J Surg. 2020;219(1):154–63.CrossRef Hajibandeh S, Hajibandeh S, Hobbs N, Mansour M. Neutrophil-to-lymphocyte ratio predicts acute appendicitis and distinguishes between complicated and uncomplicated appendicitis: a systematic review and meta-analysis. Am J Surg. 2020;219(1):154–63.CrossRef
6.
go back to reference Guclu K, Celik M. Prognostic value of inflammation parameters in patients with non-ST elevation acute coronary syndromes. Angiology. 2020;71(9):825–30.CrossRef Guclu K, Celik M. Prognostic value of inflammation parameters in patients with non-ST elevation acute coronary syndromes. Angiology. 2020;71(9):825–30.CrossRef
7.
go back to reference Wu Y, Chen Y, Yang X, Chen L, Yang Y. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus. Int Immunopharmacol. 2016;36(4):94–9.CrossRef Wu Y, Chen Y, Yang X, Chen L, Yang Y. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus. Int Immunopharmacol. 2016;36(4):94–9.CrossRef
8.
go back to reference Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124.CrossRef Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124.CrossRef
9.
go back to reference Hsu JT, Wang CC, Le PH, Chen TH, Kuo CJ, Lin CJ, et al. Lymphocyte-to-monocyte ratios predict gastric cancer surgical outcomes. J Surg Res. 2016;202(2):284–90.CrossRef Hsu JT, Wang CC, Le PH, Chen TH, Kuo CJ, Lin CJ, et al. Lymphocyte-to-monocyte ratios predict gastric cancer surgical outcomes. J Surg Res. 2016;202(2):284–90.CrossRef
10.
go back to reference Xia WK, Liu ZL, Shen D, Lin QF, Su J, Mao WD. Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma. World J Surg Oncol. 2016;14(1):127.CrossRef Xia WK, Liu ZL, Shen D, Lin QF, Su J, Mao WD. Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma. World J Surg Oncol. 2016;14(1):127.CrossRef
11.
go back to reference Vatankhah N, Jahangiri Y, Landry GJ, McLafferty RB, Alkayed NJ, Moneta GL, et al. Predictive value of neutrophil-to-lymphocyte ratio in diabetic wound healing. J Vasc Surg. 2017;65(2):478–83.CrossRef Vatankhah N, Jahangiri Y, Landry GJ, McLafferty RB, Alkayed NJ, Moneta GL, et al. Predictive value of neutrophil-to-lymphocyte ratio in diabetic wound healing. J Vasc Surg. 2017;65(2):478–83.CrossRef
12.
go back to reference Hemond CC, Glanz BI, Bakshi R, Chitnis T, Healy BC. The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosis. BMC Neurol. 2019;19(1):23.CrossRef Hemond CC, Glanz BI, Bakshi R, Chitnis T, Healy BC. The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosis. BMC Neurol. 2019;19(1):23.CrossRef
13.
go back to reference D'Amico E, Zanghì A, Romano A, Sciandra M, Palumbo GAM, Patti F. The neutrophil-to-lymphocyte ratio is related to disease activity in relapsing remitting multiple sclerosis. Cells. 2019;8(10):1114.CrossRef D'Amico E, Zanghì A, Romano A, Sciandra M, Palumbo GAM, Patti F. The neutrophil-to-lymphocyte ratio is related to disease activity in relapsing remitting multiple sclerosis. Cells. 2019;8(10):1114.CrossRef
14.
go back to reference Gelibter S, Pisa M, Croese T, Dalla Costa G, Orrico M, Preziosa P, et al. Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? J Neurol. 2021;268(2):717–23.CrossRef Gelibter S, Pisa M, Croese T, Dalla Costa G, Orrico M, Preziosa P, et al. Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? J Neurol. 2021;268(2):717–23.CrossRef
15.
go back to reference Lin J, Xue B, Li J, Xu H, Huang X, Yao Z, et al. Neutrophil to lymphocyte ratio may be a helpful marker to evaluate disease activity in NMOSD. Neurol Sci. 2017;38(10):1859–63.CrossRef Lin J, Xue B, Li J, Xu H, Huang X, Yao Z, et al. Neutrophil to lymphocyte ratio may be a helpful marker to evaluate disease activity in NMOSD. Neurol Sci. 2017;38(10):1859–63.CrossRef
16.
go back to reference Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444–52.CrossRef Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444–52.CrossRef
17.
go back to reference Conradsson D, Ytterberg C, von Koch L, Johansson S. Changes in disability in people with multiple sclerosis: a 10-year prospective study. J Neurol. 2018;265(1):119–26.CrossRef Conradsson D, Ytterberg C, von Koch L, Johansson S. Changes in disability in people with multiple sclerosis: a 10-year prospective study. J Neurol. 2018;265(1):119–26.CrossRef
18.
go back to reference Harding KE, Wardle M, Carruthers R, Robertson N, Zhu F, Kingwell E, et al. Socioeconomic status and disability progression in multiple sclerosis: a multinational study. Neurology. 2019;92(13):e1497–506 e1506.CrossRef Harding KE, Wardle M, Carruthers R, Robertson N, Zhu F, Kingwell E, et al. Socioeconomic status and disability progression in multiple sclerosis: a multinational study. Neurology. 2019;92(13):e1497–506 e1506.CrossRef
19.
go back to reference Fan R, Zhang Y, Xu Y, Tong J, Chen Z, Gu M, et al. Serum antinuclear antibodies associate with worse prognosis in AQP4-positive neuromyelitis optica spectrum disorder. Brain Behav. 2021;11(1):e01865.PubMed Fan R, Zhang Y, Xu Y, Tong J, Chen Z, Gu M, et al. Serum antinuclear antibodies associate with worse prognosis in AQP4-positive neuromyelitis optica spectrum disorder. Brain Behav. 2021;11(1):e01865.PubMed
20.
go back to reference Sepúlveda M, Aldea M, Escudero D, Llufriu S, Arrambide G, Otero-Romero S, et al. Epidemiology of NMOSD in Catalonia: influence of the new 2015 criteria in incidence and prevalence estimates. Mult Scler. 2018;24(14):1843–51.CrossRef Sepúlveda M, Aldea M, Escudero D, Llufriu S, Arrambide G, Otero-Romero S, et al. Epidemiology of NMOSD in Catalonia: influence of the new 2015 criteria in incidence and prevalence estimates. Mult Scler. 2018;24(14):1843–51.CrossRef
21.
go back to reference Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53(5):1107–14.CrossRef Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53(5):1107–14.CrossRef
22.
go back to reference Carnero Contentti E, Hryb JP, Leguizamón F, Di Pace JL, Celso J, Knorre E, et al. Differential diagnosis and prognosis for longitudinally extensive myelitis in Buenos Aires, Argentina. Neurologia. 2017;32(2):99–105.CrossRef Carnero Contentti E, Hryb JP, Leguizamón F, Di Pace JL, Celso J, Knorre E, et al. Differential diagnosis and prognosis for longitudinally extensive myelitis in Buenos Aires, Argentina. Neurologia. 2017;32(2):99–105.CrossRef
23.
go back to reference Saadoun S, Waters P, MacDonald C, Bell BA, Vincent A, Verkman AS, et al. Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain. Ann Neurol. 2012;71(3):323–33.CrossRef Saadoun S, Waters P, MacDonald C, Bell BA, Vincent A, Verkman AS, et al. Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain. Ann Neurol. 2012;71(3):323–33.CrossRef
24.
go back to reference Yick LW, Ma OK, Ng RC, Kwan JS, Chan KH. Aquaporin-4 autoantibodies from Neuromyelitis Optica Spectrum disorder patients induce complement-independent Immunopathologies in mice. Front Immunol. 2018;9:1438.CrossRef Yick LW, Ma OK, Ng RC, Kwan JS, Chan KH. Aquaporin-4 autoantibodies from Neuromyelitis Optica Spectrum disorder patients induce complement-independent Immunopathologies in mice. Front Immunol. 2018;9:1438.CrossRef
25.
go back to reference Saadoun S, Bridges LR, Verkman AS, Papadopoulos MC. Paucity of natural killer and cytotoxic T cells in human neuromyelitis optica lesions. NeuroReport. 2012;23(18):1044–7.CrossRef Saadoun S, Bridges LR, Verkman AS, Papadopoulos MC. Paucity of natural killer and cytotoxic T cells in human neuromyelitis optica lesions. NeuroReport. 2012;23(18):1044–7.CrossRef
26.
go back to reference Matsushita T, Tateishi T, Isobe N, Yonekawa T, Yamasaki R, Matsuse D, et al. Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis. PLoS One. 2013;8(4):e61835.CrossRef Matsushita T, Tateishi T, Isobe N, Yonekawa T, Yamasaki R, Matsuse D, et al. Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis. PLoS One. 2013;8(4):e61835.CrossRef
27.
go back to reference Etemadifar M, Salari M, Mirmosayyeb O, Serati M, Nikkhah R, Askari M, et al. Efficacy and safety of rituximab in neuromyelitis Optica: review of evidence. J Res Med Sci. 2017;22:18.CrossRef Etemadifar M, Salari M, Mirmosayyeb O, Serati M, Nikkhah R, Askari M, et al. Efficacy and safety of rituximab in neuromyelitis Optica: review of evidence. J Res Med Sci. 2017;22:18.CrossRef
28.
go back to reference Graber DJ, Levy M, Kerr D, Wade WF. Neuromyelitis Optica pathogenesis and aquaporin 4. J Neuroinflammation. 2008;5:22.CrossRef Graber DJ, Levy M, Kerr D, Wade WF. Neuromyelitis Optica pathogenesis and aquaporin 4. J Neuroinflammation. 2008;5:22.CrossRef
29.
go back to reference Li M, Yan Y. Experimental models of neuromyelitis Optica: current status, challenges, and future directions. Neurosci Bull. 2015;31(6):735–44.CrossRef Li M, Yan Y. Experimental models of neuromyelitis Optica: current status, challenges, and future directions. Neurosci Bull. 2015;31(6):735–44.CrossRef
30.
go back to reference Linhares UC, Schiavoni PB, Barros PO, Kasahara TM, Teixeira B, Ferreira TB, et al. The ex vivo production of IL-6 and IL-21 by CD4+ T cells is directly associated with neurological disability in neuromyelitis optica patients. J Clin Immunol. 2013;33(1):179–89.CrossRef Linhares UC, Schiavoni PB, Barros PO, Kasahara TM, Teixeira B, Ferreira TB, et al. The ex vivo production of IL-6 and IL-21 by CD4+ T cells is directly associated with neurological disability in neuromyelitis optica patients. J Clin Immunol. 2013;33(1):179–89.CrossRef
31.
go back to reference Duan T, Smith AJ, Verkman AS. Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity. Acta Neuropathol Commun. 2019;7(1):112.CrossRef Duan T, Smith AJ, Verkman AS. Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity. Acta Neuropathol Commun. 2019;7(1):112.CrossRef
32.
go back to reference Akaishi T, Takahashi T, Nakashima I, Abe M, Ishii T, Aoki M, et al. Repeated follow-up of AQP4-IgG titer by cell-based assay in neuromyelitis optica spectrum disorders (NMOSD). J Neurol Sci. 2020;410:116671.CrossRef Akaishi T, Takahashi T, Nakashima I, Abe M, Ishii T, Aoki M, et al. Repeated follow-up of AQP4-IgG titer by cell-based assay in neuromyelitis optica spectrum disorders (NMOSD). J Neurol Sci. 2020;410:116671.CrossRef
33.
go back to reference Guzel I, Mungan S, Oztekin ZN, Ak F. Is there an association between the expanded disability status scale and inflammatory markers in multiple sclerosis? J Chin Med Assoc. 2016;79(2):54–7.CrossRef Guzel I, Mungan S, Oztekin ZN, Ak F. Is there an association between the expanded disability status scale and inflammatory markers in multiple sclerosis? J Chin Med Assoc. 2016;79(2):54–7.CrossRef
34.
go back to reference He Q, Li L, Li Y, Lu Y, Wu K, Zhang R, et al. Free thyroxine level is associated with both recurrence rate and poor neurofunction in firstattack Neuromyelitis Optica Spectrum disorder (NMOSD) patients. BMC Neurol. 2019;19(1):329.CrossRef He Q, Li L, Li Y, Lu Y, Wu K, Zhang R, et al. Free thyroxine level is associated with both recurrence rate and poor neurofunction in firstattack Neuromyelitis Optica Spectrum disorder (NMOSD) patients. BMC Neurol. 2019;19(1):329.CrossRef
35.
go back to reference Ma X, Kermode AG, Hu X, Qiu W. Risk of relapse in patients with neuromyelitis optica spectrum disorder: recognition and preventive strategy. Mult Scler Relat Disord. 2020;46:102522.CrossRef Ma X, Kermode AG, Hu X, Qiu W. Risk of relapse in patients with neuromyelitis optica spectrum disorder: recognition and preventive strategy. Mult Scler Relat Disord. 2020;46:102522.CrossRef
36.
go back to reference Ma WT, Gao F, Gu K, Chen DK. The role of monocytes and macrophages in autoimmune diseases: a comprehensive review. Front Immunol. 2019;10:1140.CrossRef Ma WT, Gao F, Gu K, Chen DK. The role of monocytes and macrophages in autoimmune diseases: a comprehensive review. Front Immunol. 2019;10:1140.CrossRef
37.
go back to reference Tomczyńska M, Saluk-Bijak J. The cooperation of blood platelets and lymphocytes in the development of autoimmune thyroid diseases. Acta Biochim Pol. 2018;65(1):17–24.CrossRef Tomczyńska M, Saluk-Bijak J. The cooperation of blood platelets and lymphocytes in the development of autoimmune thyroid diseases. Acta Biochim Pol. 2018;65(1):17–24.CrossRef
Metadata
Title
Association of neutrophil-to-lymphocyte ratio (NLR) with the prognosis of first attack neuromyelitis optica spectrum disorder (NMOSD): a retrospective cohort study
Authors
Haojie Xie
Yi Zhao
Chunyang Pan
Jinwei Zhang
Yongyan Zhou
Yanfei Li
Ranran Duan
Yaobing Yao
Zhe Gong
Junfang Teng
Yanjie Jia
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2021
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-021-02432-0

Other articles of this Issue 1/2021

BMC Neurology 1/2021 Go to the issue